Proton pump inhibitors for dyspepsia

Digestive Diseases

Volumn 26, Issue 3, 2008, Pages 215-217

  Vakil, Nimish ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MARQUETTE UNIVERSITY   (United States)

^c AURORA SINAI MEDICAL CENTER   (United States)

Author keywords

Acid related disorders; Dyspepsia; Gastroesophageal reflux disease; Proton pump inhibitors

Indexed keywords

CISAPRIDE; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE;

BACTERIAL INFECTION; CANADA; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DYSPEPSIA; ERADICATION THERAPY; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SYMPTOM; UNITED KINGDOM; UNITED STATES;

DYSPEPSIA; FEMALE; FOLLOW-UP STUDIES; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HUMANS; MALE; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 43449109488     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121349     Document Type: Review

References (9)

1. Bolling-Sternevald E, Lauritsen K, Talley NJ, Junghard O, Glise H: Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia? Aliment Pharmacol Ther 2003;18:117-124.
2. Veldhuyzen van Zanten SJ, Chiba N, Armstrong D, Barkun A, Thomson A, Smyth S, Escobedo S, Lee J, Sinclair P: A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study. Am J Gastroenterol 2005;100:1477-1488.
3. Quartero AO, Numans ME, de Melker RA, Hoes AW, de Wit NJ: Dyspepsia in primary care: acid suppression as effective as prokinetic therapy. A randomized clinical trial. Scand J Gastroenterol 2001;36:942-947.
4. Talley NJ, Vakil N, Lauritsen K, van Zanten SV, Flook N, Bolling-Sternevald E, Persson T, Björck E, Lind T; STARS I Study Group. Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response? Aliment Pharmacol Ther 2007;26:673-682.
5. Moayyedi P, Delaney B, Vakil N, Forman D, Talley N: The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 2004;127:1329-1337.
6. Barton PM, Moayyedi P, Talley NJ, Vakil NB, Delaney BC: A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United States. Med Decis Making 2008;28:44-55.
7. Talley N: American Gastroenterological Association Medical Position Statement: Evaluation of Dyspepsia Gastroenterology 2005;129:1753-1755.
8. Talley NJ, Vakil N; Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005;100:2324-2337.
9. Vakil N: A BALANCING VIEW: Endoscopy in dyspepsia: a tale of two cities. Am J Gastroenterol 2007;102:476-477.